285 related articles for article (PubMed ID: 32280105)
1. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.
Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB
J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307
[TBL] [Abstract][Full Text] [Related]
3. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
[TBL] [Abstract][Full Text] [Related]
4. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohort.
Maggi G; Vitale C; Giacobbe C; Barone A; Mastromarino C; Iannotta F; Amboni M; Weintraub D; Santangelo G
Neurol Sci; 2024 Jul; 45(7):3153-3161. PubMed ID: 38231374
[TBL] [Abstract][Full Text] [Related]
6. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
[TBL] [Abstract][Full Text] [Related]
7. Impulsive-compulsive behaviors in parkin-associated Parkinson disease.
Morgante F; Fasano A; Ginevrino M; Petrucci S; Ricciardi L; Bove F; Criscuolo C; Moccia M; De Rosa A; Sorbera C; Bentivoglio AR; Barone P; De Michele G; Pellecchia MT; Valente EM
Neurology; 2016 Oct; 87(14):1436-1441. PubMed ID: 27590295
[TBL] [Abstract][Full Text] [Related]
8. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
[TBL] [Abstract][Full Text] [Related]
9. [Impulsive-compulsive syndrome in Parkinson's disease].
Nikitina AV; Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
[TBL] [Abstract][Full Text] [Related]
10. Markers of impaired motor and cognitive volition in Parkinson's disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias.
Hinkle JT; Perepezko K; Rosenthal LS; Mills KA; Pantelyat A; Mari Z; Tochen L; Bang JY; Gudavalli M; Yoritomo N; Butala A; Bakker CC; Johnson V; Moukheiber E; Dawson TM; Pontone GM
Parkinsonism Relat Disord; 2018 Feb; 47():50-56. PubMed ID: 29198499
[TBL] [Abstract][Full Text] [Related]
11. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
Wenzelburger R; Zhang BR; Pohle S; Klebe S; Lorenz D; Herzog J; Wilms H; Deuschl G; Krack P
Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
[TBL] [Abstract][Full Text] [Related]
12. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.
Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P;
Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247
[TBL] [Abstract][Full Text] [Related]
13. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [
Pagano G; Molloy S; Bain PG; Rabiner EA; Ray Chaudhuri K; Brooks DJ; Pavese N
Parkinsonism Relat Disord; 2021 Sep; 90():52-56. PubMed ID: 34385007
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
Bachmann CG; Zapf A; Brunner E; Trenkwalder C
Eur J Neurol; 2009 Aug; 16(8):895-901. PubMed ID: 19374662
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
[TBL] [Abstract][Full Text] [Related]
16. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
17. Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia.
Zhang Y; Zhu XB; Gan J; Song L; Qi C; Wu N; Wan Y; Hou M; Liu Z
J Affect Disord; 2024 Apr; 351():895-903. PubMed ID: 38342317
[TBL] [Abstract][Full Text] [Related]
18. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease.
Bellosta Diago E; Lopez Del Val LJ; Santos Lasaosa S; López Garcia E; Viloria Alebesque A
Neurologia; 2017 Oct; 32(8):494-499. PubMed ID: 27087472
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP).
Sharma A; Goyal V; Behari M; Srivastva A; Shukla G; Vibha D
Ann Indian Acad Neurol; 2015; 18(1):49-59. PubMed ID: 25745311
[TBL] [Abstract][Full Text] [Related]
20. French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
Marques A; Vidal T; Pereira B; Benchetrit E; Socha J; Pineau F; Elbaz A; Artaud F; Mangone G; You H; Cormier F; Galitstky M; Pomies E; Rascol O; Derkinderen P; Weintraub D; Corvol JC; Durif F;
Parkinsonism Relat Disord; 2019 Jun; 63():117-123. PubMed ID: 30862454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
